Literature DB >> 30587279

Primaquine for all: is it time to simplify malaria treatment in co-endemic areas?

Marcus V G Lacerda1, Quique Bassat2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30587279     DOI： 10.1016/S1473-3099(18)30612-1

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  5 in total

1.  Plasmodium vivax malaria serological exposure markers: Assessing the degree and implications of cross-reactivity with P. knowlesi.

Authors:  Rhea J Longley; Matthew J Grigg; Kael Schoffer; Thomas Obadia; Stephanie Hyslop; Kim A Piera; Narimane Nekkab; Ramin Mazhari; Eizo Takashima; Takafumi Tsuboi; Matthias Harbers; Kevin Tetteh; Chris Drakeley; Chetan E Chitnis; Julie Healer; Wai-Hong Tham; Jetsumon Sattabongkot; Michael T White; Daniel J Cooper; Giri S Rajahram; Bridget E Barber; Timothy William; Nicholas M Anstey; Ivo Mueller
Journal:  Cell Rep Med       Date:  2022-06-21

2.  Plasmodium vivax Relapse Rates Following Plasmodium falciparum Malaria Reflect Previous Transmission Intensity.

Authors:  Elizabeth A Ashley; Aung Pyae Phyo; Verena I Carrara; Kyaw Myo Tun; Francois Nosten; Frank Smithuis; Nicholas J White
Journal:  J Infect Dis       Date:  2019-06-05       Impact factor: 5.226

3.  The top 1%: quantifying the unequal distribution of malaria in Brazil.

Authors:  Raquel Lana; Narimane Nekkab; Andre M Siqueira; Cassio Peterka; Paola Marchesini; Marcus Lacerda; Ivo Mueller; Michael White; Daniel Villela
Journal:  Malar J       Date:  2021-02-12       Impact factor: 2.979

4.  Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.

Authors:  Walter R J Taylor; Saorin Kim; Sim Kheng; Sinoun Muth; Pety Tor; Eva Christophel; Mavuto Mukaka; Alexandra Kerleguer; Lucio Luzzatto; J Kevin Baird; Didier Menard
Journal:  PLoS Negl Trop Dis       Date:  2021-09-08

5.  The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network.

Authors:  Mohammad S Hossain; Robert J Commons; Nicholas M Douglas; Kamala Thriemer; Bereket H Alemayehu; Chanaki Amaratunga; Anupkumar R Anvikar; Elizabeth A Ashley; Puji B S Asih; Verena I Carrara; Chanthap Lon; Umberto D'Alessandro; Timothy M E Davis; Arjen M Dondorp; Michael D Edstein; Rick M Fairhurst; Marcelo U Ferreira; Jimee Hwang; Bart Janssens; Harin Karunajeewa; Jean R Kiechel; Simone Ladeia-Andrade; Moses Laman; Mayfong Mayxay; Rose McGready; Brioni R Moore; Ivo Mueller; Paul N Newton; Nguyen T Thuy-Nhien; Harald Noedl; Francois Nosten; Aung P Phyo; Jeanne R Poespoprodjo; David L Saunders; Frank Smithuis; Michele D Spring; Kasia Stepniewska; Seila Suon; Yupin Suputtamongkol; Din Syafruddin; Hien T Tran; Neena Valecha; Michel Van Herp; Michele Van Vugt; Nicholas J White; Philippe J Guerin; Julie A Simpson; Ric N Price
Journal:  PLoS Med       Date:  2020-11-19       Impact factor: 11.069
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.